Literature DB >> 11325347

Kainic acid-induced dorsal and ventral hippocampal seizures in rats.

K Akaike1, S Tanaka, H Tojo, S Fukumoto, S Imamura, M Takigawa.   

Abstract

Despite reports of differing regional seizure susceptibility in the hippocampus, hippocampal initiation of limbic seizures has not been precisely localized. We compared seizures induced by kainic acid microinjection into the left dorsal and ventral hippocampus of rats. Discharges following ventral injections rapidly propagated to the left amygdala and sensorimotor cortex unlike seizures following dorsal injections. The ventral group showed various ictal behaviors including motor manifestations, while dorsally injected rats showed only immobilization.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11325347     DOI： 10.1016/s0006-8993(01)02252-1

Source DB:  PubMed          Journal:  Brain Res        ISSN： 0006-8993            Impact factor:   3.252


  15 in total

Review 1.  [Effect of antipsychotics on glutaminergic neural transmission in the animal model].

Authors:  A Schmitt; B May; B Müller; M Zink; D F Braus; F A Henn
Journal:  Nervenarzt       Date:  2004-01       Impact factor: 1.214

2.  Equipotent inhibition of fatty acid amide hydrolase and monoacylglycerol lipase - dual targets of the endocannabinoid system to protect against seizure pathology.

Authors:  Vinogran Naidoo; David A Karanian; Subramanian K Vadivel; Johnathan R Locklear; JodiAnne T Wood; Mahmoud Nasr; Pamela Marie P Quizon; Emily E Graves; Vidyanand Shukla; Alexandros Makriyannis; Ben A Bahr
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

3.  The GABAA receptor-mediated recurrent inhibition in ventral compared with dorsal CA1 hippocampal region is weaker, decays faster and lasts less.

Authors:  Theodoros Petrides; Panagiotis Georgopoulos; George Kostopoulos; Costas Papatheodoropoulos
Journal:  Exp Brain Res       Date:  2007-03       Impact factor: 1.972

4.  Simultaneous lipidomic and transcriptomic profiling in mouse brain punches of acute epileptic seizure model compared to controls.

Authors:  Raissa Lerner; Julia M Post; Shane R Ellis; D R Naomi Vos; Ron M A Heeren; Beat Lutz; Laura Bindila
Journal:  J Lipid Res       Date:  2017-12-05       Impact factor: 5.922

5.  Higher susceptibility of the ventral versus the dorsal hippocampus and the posteroventral versus anterodorsal amygdala to soman-induced neuropathology.

Authors:  James P Apland; Taiza H Figueiredo; Felicia Qashu; Vassiliki Aroniadou-Anderjaska; Adriana P Souza; Maria F M Braga
Journal:  Neurotoxicology       Date:  2010-06-08       Impact factor: 4.294

6.  Three-dimensional preoperative maps of hippocampal atrophy predict surgical outcomes in temporal lobe epilepsy.

Authors:  J J Lin; N Salamon; R A Dutton; A D Lee; J A Geaga; K M Hayashi; A W Toga; J Engel; P M Thompson
Journal:  Neurology       Date:  2005-10-11       Impact factor: 9.910

7.  Effects of oxcarbazepine on monoamines content in hippocampus and head and body shakes and sleep patterns in kainic acid-treated rats.

Authors:  Alfonso Alfaro-Rodríguez; Rigoberto González-Piña; Antonio Bueno-Nava; Emilio Arch-Tirado; Alberto Ávila-Luna; Rebeca Uribe-Escamilla; Javier Vargas-Sánchez
Journal:  Metab Brain Dis       Date:  2011-07-26       Impact factor: 3.584

8.  The cause of the imbalance in the neuronal network leading to seizure activity can be predicted by the electrographic pattern of the seizure onset.

Authors:  Anatol Bragin; Avetis Azizyan; Joyel Almajano; Jerome Engel
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

9.  Mapping the electrophysiological and morphological properties of CA1 pyramidal neurons along the longitudinal hippocampal axis.

Authors:  Ruchi Malik; Kelly Ann Dougherty; Komal Parikh; Connor Byrne; Daniel Johnston
Journal:  Hippocampus       Date:  2015-10-10       Impact factor: 3.899

Review 10.  The kainic acid model of temporal lobe epilepsy.

Authors:  Maxime Lévesque; Massimo Avoli
Journal:  Neurosci Biobehav Rev       Date:  2013-10-30       Impact factor: 8.989
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.